Studies show that stopping the medication can sometimes, but not always, cause a persons weight to creep back up, along with blood pressure, blood sugar and cholesterol levels
Structurally its a pentapeptide Aib-His-D-2Nal-D-Phe-Lys-NH and those non-standard residues at positions 1 and 3 (alpha-aminoisobutyric acid and D-beta-naphthylalanine) turn out to be doing most of the pharmacological work
If you're still experiencing moderate to severe nausea after 8 weeks, your individual nausea sensitivity may benefit from genetic insight
Dont miss this rapid-fire, 25minute panel in the Opening General Session at ODAC 2026 (Jan 16): GLP1 Agonists in Cutaneous Medicine: RapidFire Insights on Comorbidities, Safety, and Aesthetic Considerations Moderator: Adam Friedman, MD, FAAD Panelists: Jennifer Soung, MD, FAAD
doi: 10.1002/dmrr.3100 140 KalaitzoglouEFowlkesJLPopescuIThrailkillKM
GLP-1 High-Conviction Addition: Long ESTA US Keeping you abreast of the situation with our GLP-1 basket, I already teased this new addition in the chat: We are adding Long ESTA as a GLP-1 secondary beneficiary at a 7.5% weight, considering my expectation that breast augmentation surgeries will see a surge in volume off the back of higher than modeled weight loss and the effects weight loss has on extra skin / breast size